Pure Global AI
NCT06002581Not yet recruiting

Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease

Clinical Study on the Efficacy and Safety of rTMS Regulating Slow-wave Sleep to Delay the Progression of Parkinson's Disease
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Parkinson's Disease
Drug/Device/Intervention
rTMS real stimulation stage1
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Timeline & enrollment
Phase
N/A
Start date
Aug 29, 2023
End date
Jul 28, 2026
Enrollment
56 participants
Primary outcome

Change of Motor Function in PD by Low Frequency rTMS Stimulation

Summary

At present, no drug therapy has been proven to delay the progression of Parkinson's disease
 (PD). rTMS, as a non-invasive neuromodulation method, can regulate Slow-wave sleep (SWS). SWS
 is recognized closely related to neurodegeneration. However, there has been no clinical
 studies on if rTMS could delay the progression of PD by regulating SWS.
 
 The main purpose of this study is to explore the changes of SWS in non-rapid eye movement
 (NREM) sleep period in PD patients by using rTMS, and the relationship with potential
 improvements of SWS and motor symptom delay. The study aims to find a potential new treatment
 strategy to delay the neurodegenerative process in PD patients by modulating SWS by rTMS.

ICD-10 classifications
Parkinson diseaseParkinsonism in diseases classified elsewhereDementia in Parkinson diseaseSecondary parkinsonismPostencephalitic parkinsonism
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06002581
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06002581 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine and is currently Not yet recruiting. The study focuses on Parkinson's Disease. Target enrollment is 56 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.